دورية أكاديمية

Marked increase in severe neurological disorders after nitrous oxide abuse: a retrospective study in the Greater Paris area.

التفاصيل البيبلوغرافية
العنوان: Marked increase in severe neurological disorders after nitrous oxide abuse: a retrospective study in the Greater Paris area.
المؤلفون: Dawudi Y; Neurology Department, Centre Hospitalier de Saint-Denis, 2 Rue du Dr Delafontaine, 93200, Saint-Denis, France. yachar.dawudi@aphp.fr.; Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136, Sorbonne Université INSERM, Paris, France. yachar.dawudi@aphp.fr., Azoyan L; Neurology Department, Centre Hospitalier de Saint-Denis, 2 Rue du Dr Delafontaine, 93200, Saint-Denis, France.; Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136, Sorbonne Université INSERM, Paris, France., Broucker TDE; Neurology Department, Centre Hospitalier de Saint-Denis, 2 Rue du Dr Delafontaine, 93200, Saint-Denis, France., Gendre T; Neurology Department, Hôpital Henri-Mondor, 1 Rue Gustave Eiffel, 94000, Créteil, France., Miloudi A; Neurology Department, Centre Hospitalier Intercommunal Robert Ballanger, Bd Robert Ballanger, 93600, Aulnay-Sous-Bois, France., Echaniz-Laguna A; Neurology Department, Hôpital Bicêtre, 78 Rue du Général Leclerc, 94270, Le Kremlin-Bicêtre, France., Mazoyer J; Neurology Department, Hôpital Avicenne, 125 Route de Stalingrad, 93009, Bobigny, France., Zanin A; Clinical Physiology Department, Hôpital Lariboisière, 2 Rue Ambroise Paré, 75010, Paris, France., Kubis N; Clinical Physiology Department, Hôpital Lariboisière, 2 Rue Ambroise Paré, 75010, Paris, France., Dubessy AL; Neurology Department, Hôpital Saint-Antoine, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France., Gorza L; Neurology Department, Hôpital Foch, 40 Rue Worth, 92150, Suresnes, France., Ben Nasr H; Neurology Department, Centre Hospitalier Sud Francilien, 40 Avenue Serge Dassault, 91100, Corbeil-Essonnes, France., Caré W; Department of Internal Medicine, Bégin Military Teaching Hospital, Saint-Mandé, France.; Paris Poison Control Center, Toxicology Federation (FeTox), Hôpital Fernand Widal, AP-HP, Paris, France., d'Izarny-Gargas T; Paris Cardiovascular Research Center, INSERM U970, Paris, France., Formoso A; Neurology Department, Hôpital de La Pitié Salpêtrière, 47-83 Bd de L'Hôpital, 75013, Paris, France., Vilcu AM; Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136, Sorbonne Université INSERM, Paris, France., Bonnan M; Neurology Department, Centre Hospitalier de Saint-Denis, 2 Rue du Dr Delafontaine, 93200, Saint-Denis, France.
المصدر: Journal of neurology [J Neurol] 2024 Jun; Vol. 271 (6), pp. 3340-3346. Date of Electronic Publication: 2024 Mar 13.
نوع المنشور: Journal Article; Multicenter Study
اللغة: English
بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Berlin ; New York, Springer-Verlag
مواضيع طبية MeSH: Nitrous Oxide*/adverse effects , Substance-Related Disorders*/epidemiology, Humans ; Male ; Female ; Adult ; Retrospective Studies ; Paris/epidemiology ; Young Adult ; Middle Aged ; Incidence ; Nervous System Diseases/epidemiology ; Nervous System Diseases/chemically induced ; Peripheral Nervous System Diseases/epidemiology ; Peripheral Nervous System Diseases/chemically induced ; Spinal Cord Diseases/epidemiology ; Spinal Cord Diseases/chemically induced ; Aged ; Adolescent ; Recreational Drug Use/statistics & numerical data
مستخلص: Background: Recreational nitrous oxide (N 2 O) use has become more widespread worldwide, leading to an increase in myelopathies and peripheral neuropathies. The aim of this study was to describe clinical and socioeconomical characteristics of severe N 2 O-induced (NI) neurological disorders (NI-NDs), to determine its incidence in the Greater Paris area and to compare it with that of similar inflammatory neurological disorders.
Methods: We performed a retrospective multicentric cohort study of all adult patients with severe NI-NDs in the neurology and general internal medicine departments of the Greater Paris area from 2018 to 2021. The incidence was compared with that of non-NI-myelitis and Guillain-Barré syndrome (GBS) using a sample of 91,000 hospitalized patients sourced from health insurance data.
Results: Among 181 patients, 25% had myelopathy, 37% had peripheral neuropathy and 38% had mixed disease. Most were aged between 20 and 25 years, lived in socially disadvantaged urban areas, and exhibited high rates of unemployment (37%). The incidence of NI-NDs increased during 2020 and reached a peak mid-2021. The 2021 incidence in 20-25-year-olds was 6.15 [4.72; 8.24] per 100,000 persons for NI-myelopathy and 7.48 [5.59; 9.37] for NI-peripheral neuropathy. This was significantly higher than for non-NI-myelitis (0.35 [0.02; 2.00]) and GBS (2.47 [0.64; 4.30]). The incidence of NI-NDs was two to three times higher in the most socially disadvantaged areas.
Conclusion: The recent increase in recreational N 2 O use has led to a rise in the incidence of severe NI-NDs, particularly in young adults with low socioeconomic status for whom NI-NDs strongly outweigh similar neurological disorders.
(© 2024. The Author(s).)
References: Sumnall H (2022) Recreational use of nitrous oxide. BMJ 378:o2297. https://doi.org/10.1136/bmj.o2297. (PMID: 10.1136/bmj.o229736167405)
Randhawa G, Bodenham A (2016) The increasing recreational use of nitrous oxide: history revisited. Br J Anaesth 116(3):321–324. https://doi.org/10.1093/bja/aev297. (PMID: 10.1093/bja/aev29726323292)
Xiang Y, Li L, Ma X et al (2021) Recreational nitrous oxide abuse: prevalence, neurotoxicity, and treatment. Neurotox Res 39(3):975–985. https://doi.org/10.1007/s12640-021-00352-y. (PMID: 10.1007/s12640-021-00352-y33770366)
Sanders RD, Weimann J, Maze M, Warner DS, Warner MA (2008) Biologic effects of nitrous oxide: a mechanistic and toxicologic review. Anesthesiology 109(4):707–722. https://doi.org/10.1097/ALN.0b013e3181870a17. (PMID: 10.1097/ALN.0b013e3181870a1718813051)
Layzer RB, Fishman RA, Schafer JA (1978) Neuropathy following abuse of nitrous oxide. Neurology 28(5):504–504. https://doi.org/10.1212/WNL.28.5.504. (PMID: 10.1212/WNL.28.5.504205816)
Zheng D, Ba F, Bi G, Guo Y, Gao Y, Li W (2020) The sharp rise of neurological disorders associated with recreational nitrous oxide use in China: a single-center experience and a brief review of Chinese literature. J Neurol 267(2):422–429. https://doi.org/10.1007/s00415-019-09600-w. (PMID: 10.1007/s00415-019-09600-w31655888)
Mair D, Paris A, Zaloum SA et al (2023) Nitrous oxide-induced myeloneuropathy: a case series. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2023-331131 . (Published online May 30, 2023). (PMID: 10.1136/jnnp-2023-33113137253616)
Guerlais M, Aquizerate A, Lionnet A et al (2023) Nitrous oxide: a unique official French addictovigilance national survey. Front Public Health 11:1167746. https://doi.org/10.3389/fpubh.2023.1167746. (PMID: 10.3389/fpubh.2023.11677463720687110189051)
Scailteux LM, Droitcourt C, Balusson F et al (2019) French administrative health care database (SNDS): the value of its enrichment. Therapies 74(2):215–223. https://doi.org/10.1016/j.therap.2018.09.072. (PMID: 10.1016/j.therap.2018.09.072)
Oussalah A, Julien M, Levy J et al (2019) Global burden related to nitrous oxide exposure in medical and recreational settings: a systematic review and individual patient data meta-analysis. J Clin Med 8(4):551. https://doi.org/10.3390/jcm8040551. (PMID: 10.3390/jcm8040551310186136518054)
Accueil | Direction de la recherche, des études, de l’évaluation et des statistiques. Accessed Nov 1, 2023. https://drees.solidarites-sante.gouv.fr/.
Accueil - Insee - Institut national de la statistique et des études économiques. Accessed Nov 1, 2023. https://www.insee.fr/fr/accueil.
Rosenberg H, Orkin FK, Springstead J (1979) Abuse of nitrous oxide. Anesth Analg 58(2):104–106. (PMID: 10.1213/00000539-197903000-00009571232)
Kaar SJ, Ferris J, Waldron J, Devaney M, Ramsey J, Winstock AR (2016) Up: the rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use. J Psychopharmacol 30(4):395–401. https://doi.org/10.1177/0269881116632375. (PMID: 10.1177/026988111663237526912510)
van Amsterdam J, Nabben T, van den Brink W (2015) Recreational nitrous oxide use: prevalence and risks. Regul Toxicol Pharmacol 73(3):790–796. https://doi.org/10.1016/j.yrtph.2015.10.017. (PMID: 10.1016/j.yrtph.2015.10.01726496821)
Thevenin M (2023) Épidémiologie de la consommation récréative de protoxyde d’azote chez les étudiants en médecine d’Ile-de-France. Doctoral thesis. Université Paris Cité.
Winstock AR, Ferris JA (2020) Nitrous oxide causes peripheral neuropathy in a dose dependent manner among recreational users. J Psychopharmacol 34(2):229–236. https://doi.org/10.1177/0269881119882532. (PMID: 10.1177/026988111988253231679459)
Barnhill JW (2013) DSM-5® clinical cases. American Psychiatric Pub. (PMID: 10.1176/appi.books.9781585624836)
Wu G, Wang S, Wang T et al (2022) Neurological and psychological characteristics of young nitrous oxide abusers and its underlying causes during the COVID-19 lockdown. Front Public Health 10:854977. https://doi.org/10.3389/fpubh.2022.854977. (PMID: 10.3389/fpubh.2022.854977357196239201030)
Nabben T, Weijs J, van Amsterdam J (2021) Problematic use of nitrous oxide by young moroccan-dutch adults. Int J Environ Res Public Health 18(11):5574. https://doi.org/10.3390/ijerph18115574. (PMID: 10.3390/ijerph18115574340710878197142)
Lapeyre-Mestre M, Boucher A, Daveluy A et al (2020) Addictovigilance contribution during COVID-19 epidemic and lockdown in France. Therapie 75(4):343–354. https://doi.org/10.1016/j.therap.2020.06.006. (PMID: 10.1016/j.therap.2020.06.006326607767309935)
Bethmont A, Harper CE, Chan BS, Dawson AH, McAnulty J (2019) Increasing illicit use of nitrous oxide in presentations to NSW emergency departments. Med J Aust 211(9):429–429. https://doi.org/10.5694/mja2.50377 . (e1). (PMID: 10.5694/mja2.5037731625166)
European Monitoring Centre for Drugs and Drug Addiction. Recreational nitrous oxide use in Europe: situation, risks, responses. Accessed Nov 4, 2023. https://www.emcdda.europa.eu/publications/topic-overviews/recreational-nitrous-oxide-use-europe-situation-risks-responses_en.
Winstock A, Munksgaard R, Davies E, Ferris J, ZhuParris A, Barratt M (2022) Drug trend report: time, music, clubbing, age, and diet. Global Drug Survey.
فهرسة مساهمة: Keywords: Epidemiology; Myelopathy; Nitrous oxyde abuse; Peripheral neuropathy
المشرفين على المادة: K50XQU1029 (Nitrous Oxide)
تواريخ الأحداث: Date Created: 20240313 Date Completed: 20240529 Latest Revision: 20240718
رمز التحديث: 20240719
مُعرف محوري في PubMed: PMC11136741
DOI: 10.1007/s00415-024-12264-w
PMID: 38478030
قاعدة البيانات: MEDLINE
الوصف
تدمد:1432-1459
DOI:10.1007/s00415-024-12264-w